Genome wide gene expression studies in mood disorders.
Microarrays offer the possibility of screening in parallel virtually all genes expressed in a given tissue or to study the molecular signature associated with available treatments. As such, this technology has been increasingly used to investigate multifactorial and polygenic complex traits such as psychiatric disorders, in particular, schizophrenia and mood disorders. This review focuses on microarray studies investigating mood disorders. Study designs, methodologic approaches and limitations, subsequent follow-up strategies, and confirmation of results are discussed. Despite the apparent disparate and not always concordant results, it appears evident that this technology is a powerful and inevitable approach for the study of mood disorders, especially when phenotype-specific confounders are properly accounted for. Thus, alterations of mitochondrial, oligodendrocyte, and myelin related genes in bipolar disorder, of signaling and olidendroglial related genes in depression, and of GABA-glutamate related genes in depression and suicide have been observed and have confirmed new avenues for the study and the treatment of these complex disorders.
Sequeira
Adolfo
A
McGill Group for Suicide Studies, Douglas Hospital, McGill University, Verdun, Quebec, Canada.
Turecki
Gustavo
G
D020869:Gene Expression Profiling; D015894:Genome, Human / Q000502:physiology*; D006801:Humans; D019964:Mood Disorders / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis